The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System
Open accessThe DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Abstract
Estrogen has important effects on cardiovascular function including regulation of vascular function, blood pressure, endothelial relaxation, and the development of hypertrophy and cardioprotection. However, the mechanisms by which estrogen mediates these effects are still poorly understood. As detailed in this review, estrogen can regulate transcription by binding to 2 nuclear receptors, ERα and ERβ, which differentially regulate gene transcription. ERα and ERβ regulation of gene transcription is further modulated by tissue-specific coactivators and corepressors. Estrogen can bind to ERα and ERβ localized at the plasma membrane as well as G-protein–coupled estrogen receptor to initiate membrane delimited signaling, which enhances kinase signaling pathways that can have acute and long-term effects. The kinase signaling pathways can also mediate transcriptional changes and can synergize with the ER to regulate cell function. This review will summarize the beneficial effects of estrogen in protecting the cardiovascular system through ER-dependent mechanisms with an emphasis on the role of the recently described ER membrane signaling mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
Owens, G. K., Kumar, M. S., & Wamhoff, B. R. (2004) · Physiological Reviews · doi:10.1152/physrev.00041.2003 · Cited by 3,471 · cited 1×
“Normally, VSMC proliferation is slow; however, during stress, such as atherosclerosis or hypertension, these cells increase the rate of proliferation and migration.(138) Estrogen decreases VSMC proliferation after injury.”
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,431 · cited 1×
“protein-1 activity is regulated via MAPK-mediated phosphorylation.(152) Estrogen can activate MAPK signaling that results”
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302 · cited 1×
“Two independent groups found that estrogen can directly bind to GPER at the membrane in monkey kidney fibroblast cells and breast cancer cells.(72,118) Haas et al(120) later discovered GPER expression in VSMC of human arteries and veins and confirmed that this novel receptor is regulated by estrogen.”
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269
Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,930 · cited 1×
“Large randomized clinical trials did not show a benefit with hormonereplacement therapy.(6,7) However, a recent update of the woman health initiative examined different age groups and concluded that hormone-replacement therapy “has a harmful effect on coronary heart disease among older women, whereas the results in yo…”
Policy: NIH to balance sex in cell and animal studies
Clayton, J. A., & Collins, F. S. (2014) · Nature · doi:10.1038/509282a · Cited by 1,816 · cited 1×
“the National Institutes of Health has recently called for the inclusion of both sexes in preclinical trials.(11) Without a better”
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436 · cited 1×
“Indeed, mice treated with estrogen showed increased eNOS activity and decreased vascular leukocyte accumulation after I/R injury, and this vascular protective effect of estrogen was abolished in the presence of inhibitors of PI3K or eNOS.(92) ERα can also interact with the G proteins Gαi and Gβγ through amino acids 25…”
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Thomas, P., Pang, Y., Filardo, E. J., & Dong, J. (2005) · Endocrinology · doi:10.1210/en.2004-1064 · Cited by 1,407 · cited 1×
“Two independent groups found that estrogen can directly bind to GPER at the membrane in monkey kidney fibroblast cells and breast cancer cells.(72,118) Haas et al(120) later discovered GPER expression in VSMC of human arteries and veins and confirmed that this novel receptor is regulated by estrogen.”
Filardo, E. J. (2000) · Molecular Endocrinology · doi:10.1210/me.14.10.1649 · Cited by 1,383
Cited by
Iorga, A., Cunningham, C. M., Moazeni, S., Ruffenach, G., Umar, S., & Eghbali, M. (2017) · Biology of Sex Differences · doi:10.1186/s13293-017-0152-8 · Cited by 914
“While there is abundant data supporting E2 as a cardoprotective agent in experimental models of CVD, E2 replacement therapy in postmenopausal women has been very controversial [5].”
BackgroundMaas, A. H. E. M., Rosano, G., Cifkova, R., Chieffo, A., van Dijken, D., Hamoda, H., Kunadian, V., Laan, E., Lambrinoudaki, I., Maclaran, K., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa1044 · Cited by 344
Role of estrogen receptors in health and disease
Chen, P., Li, B., & Ou-Yang, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.839005 · Cited by 339
Neutrophils in Post-myocardial Infarction Inflammation: Damage vs. Resolution?
Puhl, S.-L., & Steffens, S. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00025 · Cited by 196
Regulatory Actions of Estrogen Receptor Signaling in the Cardiovascular System
Ueda, K., Adachi, Y., Liu, P., Fukuma, N., & Takimoto, E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00909 · Cited by 60
“These recent clinical findings encourage researchers to further investigate molecular and physiological function of ERmediated signaling in the cardiovascular system (12, 13), which provides meaningful steps forward to the development of a next generation of HT for women that capture the beneficial cardiovascular effe…”
Background
Metadata
- Authors
- Menazza, S., & Murphy, E.
- Venue
- Circulation Research
- Published
- 2016-03-18
- Volume
- 118
- Issue
- 6
- Pages
- 994-1007
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2226007603
- Cited by
- 210
- References
- 166
- FWCI
- 15.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System. https://app.cochat.ai/papers/10.1161/circresaha.115.305376
- The paper
- Menazza, S., & Murphy, E. (2016). The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System. Circulation Research. https://doi.org/10.1161/circresaha.115.305376
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.